Current Prices from Adial Pharmaceuticals, Inc - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ADIL	USD	13.06.2025 23:57	0,35 USD	0,45 USD -22,61 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-40,00 %	-46,05 %	-48,06 %	-68,07 %	-73,23 %	-99,06 %

Company Profile for Adial Pharmaceuticals, Inc - Common Stock Share

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Company Data

Name Adial Pharmaceuticals, Inc - Common Stock

Company Adial Pharmaceuticals, Inc.

Symbol ADIL

Website https://www.adialpharma.com

Primary Exchange

NASDAQ

ISIN US00688A2050

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Cary John Claiborne MBA

Country United States of America

Currency USD

Employees 0,0 T

Address 1180 Seminole Trail, 22901 Charlottesville

IPO Date 2018-07-27

Ticker Symbols

Name	Symbol
NASDAQ	ADIL

More Shares

Investors who Adial Pharmaceuticals, Inc - Common Stock hold also have the following shares in their portfolio:

ACAT.GANE VALUE EVENT F.A Fund

OOREDOO INTERNATIONAL FINANCE LIMITED 4.75% GTD NTS 16/02/21 (REG S) Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog